Perspective Therapeutics, Inc. Quarterly Selling and Marketing Expense in USD from Q3 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Perspective Therapeutics, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q3 2010 to Q3 2023.
  • Perspective Therapeutics, Inc. Selling and Marketing Expense for the quarter ending September 30, 2023 was $855K, a 6.88% increase year-over-year.
  • Perspective Therapeutics, Inc. annual Selling and Marketing Expense for 2022 was $2.8M, a 14.9% increase from 2021.
  • Perspective Therapeutics, Inc. annual Selling and Marketing Expense for 2021 was $2.44M, a 18% decline from 2020.
  • Perspective Therapeutics, Inc. annual Selling and Marketing Expense for 2020 was $2.98M, a 11.1% increase from 2019.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $855K +$55K +6.88% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $911K +$257K +39.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $812K +$125K +18.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q3 2022 $2.84M $800K +$39K +5.13% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $2.8M $654K -$5K -0.76% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $2.81M $687K +$106K +18.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $2.7M $702K +$83K +13.4% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-09
Q3 2021 $2.62M $761K +$180K +31% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.44M $659K -$31K -4.49% Apr 1, 2021 Jun 30, 2021 10-KT 2023-05-01
Q1 2021 $2.47M $581K -$224K -27.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $2.7M $619K -$47K -7.06% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $2.74M $581K -$234K -28.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $2.98M $690K +$7K +1.03% Apr 1, 2020 Jun 30, 2020 10-KT 2023-05-01
Q1 2020 $2.97M $805K +$160K +24.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $2.81M $666K -$36K -5.13% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $2.85M $815K +$166K +25.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $2.68M $683K +$3K +0.44% Apr 1, 2019 Jun 30, 2019 10-K 2021-09-27
Q1 2019 $2.68M $645K -$47K -6.79% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $2.72M $702K +$28K +4.15% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-12
Q3 2018 $2.7M $649K +$35K +5.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $2.66M $680K -$80K -10.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-09-25
Q1 2018 $2.74M $692K +$162K +30.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $2.58M $674K +$178K +35.9% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 $2.4M $614K +$90K +17.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $2.31M $760K +$240K +46.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-09-27
Q1 2017 $2.07M $530K +$229K +76.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $1.84M $496K +$242K +95.3% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $1.6M $524K +$246K +88.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $1.35M $520K +$64.4K +14.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-09-26
Q1 2016 $1.29M $301K -$73.9K -19.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $1.36M $254K -$49.8K -16.4% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $1.41M $278K -$75.7K -21.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $1.49M $456K +$152K +50.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-28
Q1 2015 $1.34M $375K +$129K +52.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $1.21M $304K -$22.7K -6.95% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $1.23M $354K -$5.44K -1.52% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $1.23M $304K -$63.7K -17.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-09-09
Q1 2014 $1.3M $246K -$45.3K -15.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $1.34M $326K +$4.37K +1.36% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $1.34M $359K +$43.1K +13.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $1.3M $367K +$29.2K +8.63% Apr 1, 2013 Jun 30, 2013 10-K 2015-09-14
Q1 2013 $1.27M $291K +$31.8K +12.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $1.24M $322K +$18K +5.91% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 $1.22M $316K +$1.64K +0.52% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $1.22M $338K +$50.1K +17.4% Apr 1, 2012 Jun 30, 2012 10-K 2013-09-30
Q1 2012 $1.17M $259K +$23.8K +10.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $1.14M $304K -$31.5K -9.38% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 $1.17M $314K -$59K -15.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $1.23M $288K Apr 1, 2011 Jun 30, 2011 10-K/A 2012-10-26
Q1 2011 $235K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 $336K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 $373K Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-12-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.